SCHIZOPHRENIA 1 (Disorder): Clinical Trials

40 trials for SCHIZOPHRENIA 1 (Disorder), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 not yet recruiting, 12 completed, 9 recruiting, 1 unknown. 26 Not applicable, 4 Phase 2, 2 Phase 1, 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable26Not yet recruiting 10, Completed 9, Recruiting 6, Unknown 1
Phase 24Recruiting 2, Completed 1, Not yet recruiting 1
Phase 12Completed 1, Recruiting 1
Phase 32Not yet recruiting 2
Phase 41Not yet recruiting 1

Follow SCHIZOPHRENIA 1 (Disorder): new trials by email Literature Review of SCHIZOPHRENIA 1 (Disorder) trials Research Report on SCHIZOPHRENIA 1 (Disorder)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2
Motion Perception Task, Sine Wave Speech Task, Volatility Task - SCHIZOPHRENIA 1 (Disorder), Schizo Affective Disorder
Not applicableNot yet recruitingWashington University School of Medicine3252028-04-012026-11-09
Developing a Virtual Reality-assisted Intervention for Emotion Regulation Difficulties in Psychosis
MANOEUVRE therapy - Psychosis, SCHIZOPHRENIA 1 (Disorder)
Not applicableNot yet recruitingKing's College London152027-09-012026-06-03
Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual Treatment
Bipolar Disorder (BD), SCHIZOPHRENIA 1 (Disorder)
Not yet recruitingInternational University of La Rioja302027-02-012026-11-06
Brain Imaging of DSP-2342
DSP-2342 - SCHIZOPHRENIA 1 (Disorder)
Phase 2Not yet recruitingJohns Hopkins University202027-01-012026-09-30
Online Intervention To Improve Motivation
Online Motivation Enhancing Intervention - Schizophrenia Prodromal, SCHIZOPHRENIA 1 (Disorder)
Not applicableNot yet recruitingUniversity of Alabama at Birmingham602026-12-012026-10-13
Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 3
Motion Perception Task, Sine Wave Speech Task, Volatility Task - Schizophrenia / Schizoaffective Disorder, SCHIZOPHRENIA 1 (Disorder)
Not applicableRecruitingWashington University School of Medicine100002026-12-012026-11-09
Higher-Dose Maintenance With ERZOFRI 351 mg in Adults With Schizophrenia
Paliperidone Palmitate - SCHIZOPHRENIA 1 (Disorder)
Phase 4Not yet recruitingAlejandro Alva402026-12-012026-11-10
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
Motion Perception Task, Sine Wave Speech Task, Volatility Task - SCHIZOPHRENIA 1 (Disorder), Schizoaffective Disorder
Not applicableRecruitingWashington University School of Medicine3252026-11-152026-11-09
Confirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophrenia
EEG Neurofeedback - SCHIZOPHRENIA 1 (Disorder), Schizoaffecitve Disorder
Phase 2RecruitingUniversity of California, San Diego1042026-11-052026-11-10
Phase 3 Study of HS-10380 for Acute Schizophrenia in Chinese Adults
HS-10380, Aripiprazole, Placebo - SCHIZOPHRENIA 1 (Disorder)
Phase 3Not yet recruitingJiangsu Hansoh Pharmaceutical Co., Ltd.4762026-11-042026-11-03
The Effect of ACT-Based Nursing Interventions on Social Cognition, Emotion Regulation and Psychological Flexibility in Patients With Schizophrenia
Acceptance and Commitment Therapy (ACT)-Based Nursing Intervention - SCHIZOPHRENIA 1 (Disorder)
Not applicableNot yet recruitingAtaturk University642026-10-012026-06-22
Multi-target TMS for Schizophrenia Negative Symptoms
repetitive transcranial magnetic stimulation (rTMS) - SCHIZOPHRENIA 1 (Disorder)
Not applicableNot yet recruitingShanghai Mental Health Center642026-10-012026-09-10
Time Course of Clozapine-associated Agranulocytosis Over 19 Years
Agranulocytosis, Neutropenia
CompletedSheba Medical Center20202026-09-102026-11-03
A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
HS-10380 - SCHIZOPHRENIA 1 (Disorder)
Phase 3Not yet recruitingJiangsu Hansoh Pharmaceutical Co., Ltd.5002026-09-092026-08-12
Basal Stimulation Therapy in Adults With Schizophrenia Requiring Institutional Care
physiotherapy, 2 x a week for 6 weeks, basal therapy, 2 x a week for 6 weeks, Standard therapy group - SCHIZOPHRENIA 1 (Disorder)
Not applicableNot yet recruitingThe Jerzy Kukuczka Academy of Physical Education in Katowice122026-09-012026-08-18
Snoezelen Therapy in Adults With Alcohol Dependence and Adults With Schizophrenia
Snoezelen® therapy for 6 weeks, Snoezelen® therapy for 12 weeks - SCHIZOPHRENIA 1 (Disorder), Alcohol Use Disorder
Not applicableNot yet recruitingThe Jerzy Kukuczka Academy of Physical Education in Katowice1402026-09-012026-08-05
Ultrasound Assessment of Gluteal Muscle in Patients Receiving Depot Antipsychotics and Healthy Volunteers
Psychotic Disorder, SCHIZOPHRENIA 1 (Disorder)
Not yet recruitingSt. Olavs Hospital602026-09-012026-09-11
Building a Computational Model of Auditory Hallucinations
Schizophrenia / Schizoaffective Disorder, Schizophrenia and Disorders With Psychotic Feature
Not yet recruitingKing's College London1462026-09-012026-09-15
Nurse-Led Simulation-Based Prosocial Skills Training in Individuals With Schizophrenia
Nurse-Led Simulation-Based Prosocial Skills Training - SCHIZOPHRENIA 1 (Disorder)
Not applicableCompletedSelcuk University502026-08-032026-11-13
ACT-Based Psychoeducation for Caregivers of Patients With Schizophrenia
Acceptance and Commitment Therapy (ACT)-Based Psychoeducation Program - SCHIZOPHRENIA 1 (Disorder)
Not applicableNot yet recruitingAydin Adnan Menderes University602026-07-012026-06-18

Showing 20 of 40. Sign in to see all of them.

Narrower conditions

Schizophrenia (28)  ·  Psychotic Disorders (10)  ·  Emotional Regulation (2)  ·  Schizotypal Personality Disorder (2)  ·  Agranulocytosis (1)  ·  Alcoholism (1)  ·  Anxiety Disorders (1)  ·  Bipolar Disorder (1)  ·  Borderline Personality Disorder (1)  ·  Depressive Disorder, Major (1)  ·  Generalized Anxiety Disorder (1)  ·  Hallucinations (1)  ·  Mental Disorders (1)  ·  Metabolic Syndrome (1)  ·  Neutropenia (1)

Broader conditions

Mental Disorders (33)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (32)  ·  Behavior (4)  ·  Nervous System Diseases (3)  ·  Personality Disorders (3)  ·  Chemically-Induced Disorders (2)  ·  Mood Disorders (2)  ·  Self-Control (2)  ·  Sleep Wake Disorders (2)  ·  Social Behavior (2)  ·  Alcohol-Related Disorders (1)  ·  Bipolar and Related Disorders (1)  ·  Cytopenia (1)  ·  Depressive Disorder (1)  ·  Dyssomnias (1)

Interventions

Aripiprazole (2)  ·  Exercise (1)  ·  Eye Movement Desensitization Reprocessing (1)  ·  Fluvoxamine (1)  ·  Observation (1)  ·  Paliperidone Palmitate (1)  ·  Physical Therapy Modalities (1)  ·  Transcranial Direct Current Stimulation (1)  ·  Transcranial Magnetic Stimulation (1)  ·  Waiting Lists (1)  ·  cariprazine (1)  ·  trospium chloride (1)  ·  xanomeline (1)

Sponsors

Jiangsu Hansoh Pharmaceutical Co., Ltd. (3)  ·  Washington University School of Medicine (3)  ·  King's College London (2)  ·  The Hashemite University (2)  ·  The Jerzy Kukuczka Academy of Physical Education in Katowice (2)  ·  Alejandro Alva (1)  ·  Ataturk University (1)  ·  Aydin Adnan Menderes University (1)  ·  Azienda Sanitaria Locale Napoli 3 Sud, UOCSM Torre del Greco (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Dicle University (1)  ·  Humanis Saglık Anonim Sirketi (1)  ·  Hôpital le Vinatier (1)  ·  International University of La Rioja (1)  ·  Johns Hopkins University (1)

Countries

United States (10)  ·  Turkey (Türkiye) (6)  ·  China (4)  ·  Denmark (2)  ·  Israel (2)  ·  Poland (2)  ·  Spain (2)  ·  Egypt (1)  ·  France (1)  ·  India (1)  ·  Italy (1)  ·  Jordan (1)  ·  United Kingdom (1)

Top investigators

Deanna Barch, PhD (2)  ·  Laura Piejko, PT, PhD (2)  ·  Nikolai Albert (2)  ·  Abdallah Abu Khait, Ph.D.,MSN (1)  ·  Akira Sawa, MD (1)  ·  Alejandro Alva, MD (1)  ·  Antigona Martinez, PhD (1)  ·  Daniel C Javitt, MD, PhD (1)  ·  Deanna Barch, Ph.D. (1)  ·  Dr Caroline Lawlor (1)  ·  Felice F. Carabellese, Medical doctor, Full Professor (1)  ·  Fiza Singh, MD (1)

Results publications

PMID 33861952, PMID 33914891, PMID 36418846, PMID 36711165, PMID 39117276, PMID 40063391, PMID 42184934, PMID 21334602, PMID 22710617, PMID 23522057, PMID 23817024, PMID 25273286, PMID 25979608, PMID 26160288, PMID 26200928, PMID 26494483, PMID 28406662, PMID 28740827, PMID 30260448, PMID 30704863, PMID 30953588, PMID 31811557, PMID 32799938, PMID 33878489, PMID 35128308, PMID 36173600, PMID 36931706, PMID 37314113, PMID 38616053, PMID 22035996, PMID 24037621, PMID 25675960, PMID 27239096, PMID 34598786, PMID 34647290, PMID 35237135, PMID 42568860

NIH funding

R01MH084840 (3), R01MH138939 (1)